Striatal dopamine transporter availability in unmedicated bipolar disorder

Amit Anand, Gavriel Barkay, Mario Dzemidzic, Daniel Albrecht, Harish Karne, Qi-Huang Zheng, Gary Hutchins, Marc D. Normandin, Karmen Yoder

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objectives: Dopamine transmission abnormalities have been implicated in the etiology of bipolar disorder (BPD). However, there is a paucity of receptor imaging studies in BPD, and little information is available about the dopamine system in BPD. Reuptake of synaptic dopamine by the dopamine transporter (DAT) is the principal mechanism regulating dopamine neurotransmission, and is often used as a marker for presynaptic dopamine function. This positron emission tomography (PET) study investigated whether DAT availability differed between BPD and healthy control subjects. Methods: A total of 11 unmedicated BPD patients in either the euthymic or depressed phase and 13 closely matched healthy subjects underwent PET imaging with the DAT-selective radiotracer [ 11C]CFT and a structural magnetic resonance imaging (MRI) scan. Striatal binding potential (BP ND) was estimated using the multilinear reference tissue model. Region of interest and analyses were conducted to test for differences in [ 11C]CFT BP ND between groups. Results: Unmedicated BPD subjects had significantly lower DAT availability relative to healthy controls in bilateral dorsal caudate. Conclusions: The results of this study support the hypothesis that there are abnormalities in the dopaminergic system in BPD, and suggest that DAT availability may be related to the neuropathology of BPD. Future studies are needed to determine if DAT availability cycles with disease phase.

Original languageEnglish
Pages (from-to)406-413
Number of pages8
JournalBipolar Disorders
Volume13
Issue number4
DOIs
StatePublished - Jun 2011

Fingerprint

Corpus Striatum
Dopamine Plasma Membrane Transport Proteins
Bipolar Disorder
Dopamine
Positron-Emission Tomography
Healthy Volunteers
Synaptic Transmission
Magnetic Resonance Imaging

Keywords

  • [ C]CFT
  • Bipolar disorder
  • Dopamine
  • Dopamine transporter
  • Positron emission tomography
  • Striatum

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Striatal dopamine transporter availability in unmedicated bipolar disorder. / Anand, Amit; Barkay, Gavriel; Dzemidzic, Mario; Albrecht, Daniel; Karne, Harish; Zheng, Qi-Huang; Hutchins, Gary; Normandin, Marc D.; Yoder, Karmen.

In: Bipolar Disorders, Vol. 13, No. 4, 06.2011, p. 406-413.

Research output: Contribution to journalArticle

Anand, Amit ; Barkay, Gavriel ; Dzemidzic, Mario ; Albrecht, Daniel ; Karne, Harish ; Zheng, Qi-Huang ; Hutchins, Gary ; Normandin, Marc D. ; Yoder, Karmen. / Striatal dopamine transporter availability in unmedicated bipolar disorder. In: Bipolar Disorders. 2011 ; Vol. 13, No. 4. pp. 406-413.
@article{a0b2b5d7b2464b3ba5035823c0743bae,
title = "Striatal dopamine transporter availability in unmedicated bipolar disorder",
abstract = "Objectives: Dopamine transmission abnormalities have been implicated in the etiology of bipolar disorder (BPD). However, there is a paucity of receptor imaging studies in BPD, and little information is available about the dopamine system in BPD. Reuptake of synaptic dopamine by the dopamine transporter (DAT) is the principal mechanism regulating dopamine neurotransmission, and is often used as a marker for presynaptic dopamine function. This positron emission tomography (PET) study investigated whether DAT availability differed between BPD and healthy control subjects. Methods: A total of 11 unmedicated BPD patients in either the euthymic or depressed phase and 13 closely matched healthy subjects underwent PET imaging with the DAT-selective radiotracer [ 11C]CFT and a structural magnetic resonance imaging (MRI) scan. Striatal binding potential (BP ND) was estimated using the multilinear reference tissue model. Region of interest and analyses were conducted to test for differences in [ 11C]CFT BP ND between groups. Results: Unmedicated BPD subjects had significantly lower DAT availability relative to healthy controls in bilateral dorsal caudate. Conclusions: The results of this study support the hypothesis that there are abnormalities in the dopaminergic system in BPD, and suggest that DAT availability may be related to the neuropathology of BPD. Future studies are needed to determine if DAT availability cycles with disease phase.",
keywords = "[ C]CFT, Bipolar disorder, Dopamine, Dopamine transporter, Positron emission tomography, Striatum",
author = "Amit Anand and Gavriel Barkay and Mario Dzemidzic and Daniel Albrecht and Harish Karne and Qi-Huang Zheng and Gary Hutchins and Normandin, {Marc D.} and Karmen Yoder",
year = "2011",
month = "6",
doi = "10.1111/j.1399-5618.2011.00936.x",
language = "English",
volume = "13",
pages = "406--413",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "4",

}

TY - JOUR

T1 - Striatal dopamine transporter availability in unmedicated bipolar disorder

AU - Anand, Amit

AU - Barkay, Gavriel

AU - Dzemidzic, Mario

AU - Albrecht, Daniel

AU - Karne, Harish

AU - Zheng, Qi-Huang

AU - Hutchins, Gary

AU - Normandin, Marc D.

AU - Yoder, Karmen

PY - 2011/6

Y1 - 2011/6

N2 - Objectives: Dopamine transmission abnormalities have been implicated in the etiology of bipolar disorder (BPD). However, there is a paucity of receptor imaging studies in BPD, and little information is available about the dopamine system in BPD. Reuptake of synaptic dopamine by the dopamine transporter (DAT) is the principal mechanism regulating dopamine neurotransmission, and is often used as a marker for presynaptic dopamine function. This positron emission tomography (PET) study investigated whether DAT availability differed between BPD and healthy control subjects. Methods: A total of 11 unmedicated BPD patients in either the euthymic or depressed phase and 13 closely matched healthy subjects underwent PET imaging with the DAT-selective radiotracer [ 11C]CFT and a structural magnetic resonance imaging (MRI) scan. Striatal binding potential (BP ND) was estimated using the multilinear reference tissue model. Region of interest and analyses were conducted to test for differences in [ 11C]CFT BP ND between groups. Results: Unmedicated BPD subjects had significantly lower DAT availability relative to healthy controls in bilateral dorsal caudate. Conclusions: The results of this study support the hypothesis that there are abnormalities in the dopaminergic system in BPD, and suggest that DAT availability may be related to the neuropathology of BPD. Future studies are needed to determine if DAT availability cycles with disease phase.

AB - Objectives: Dopamine transmission abnormalities have been implicated in the etiology of bipolar disorder (BPD). However, there is a paucity of receptor imaging studies in BPD, and little information is available about the dopamine system in BPD. Reuptake of synaptic dopamine by the dopamine transporter (DAT) is the principal mechanism regulating dopamine neurotransmission, and is often used as a marker for presynaptic dopamine function. This positron emission tomography (PET) study investigated whether DAT availability differed between BPD and healthy control subjects. Methods: A total of 11 unmedicated BPD patients in either the euthymic or depressed phase and 13 closely matched healthy subjects underwent PET imaging with the DAT-selective radiotracer [ 11C]CFT and a structural magnetic resonance imaging (MRI) scan. Striatal binding potential (BP ND) was estimated using the multilinear reference tissue model. Region of interest and analyses were conducted to test for differences in [ 11C]CFT BP ND between groups. Results: Unmedicated BPD subjects had significantly lower DAT availability relative to healthy controls in bilateral dorsal caudate. Conclusions: The results of this study support the hypothesis that there are abnormalities in the dopaminergic system in BPD, and suggest that DAT availability may be related to the neuropathology of BPD. Future studies are needed to determine if DAT availability cycles with disease phase.

KW - [ C]CFT

KW - Bipolar disorder

KW - Dopamine

KW - Dopamine transporter

KW - Positron emission tomography

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=80051630282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051630282&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5618.2011.00936.x

DO - 10.1111/j.1399-5618.2011.00936.x

M3 - Article

C2 - 21843280

AN - SCOPUS:80051630282

VL - 13

SP - 406

EP - 413

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - 4

ER -